SCHEMBL7127937

SCHEMBL7127937

CC(C1CCCN1)N1CCC(CC[O])CC1

nearest known ligand 0.33

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 1/20 0.32
HRH3 Q9Y5N1 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7129871 0.95 SLC6A3 (0.34) SIGMAR1
SCHEMBL7128351 0.92 HRH3 (0.33) SIGMAR1HRH3
SCHEMBL7126837 0.81 SLC6A2 (0.31)
SCHEMBL7127976 0.77 SLC6A2 (0.35)
SCHEMBL6079957 0.77 SLC6A2 (0.34)
SCHEMBL27980514 0.75 SIGMAR1 (0.34) SIGMAR1
SCHEMBL4374285 0.73 HRH3 (0.45) HRH3
SCHEMBL7123110 0.72
SCHEMBL6968694 0.72 SLC6A3 (0.40)
SCHEMBL4628866 0.70 SLC6A3 (0.39) SIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1311500-A2 INDOLE, AZAINDOLE AND INDAZOLE DERIVATIVES HAVING VEGF INHIBITING ACTIVITY AstraZeneca AB (SE) 2003-05-21 EP disclosed
EP-1309587-A1 CINNOLINE COMPOUNDS AstraZeneca AB (SE) 2003-05-14 EP disclosed
WO-2002016348-A1 ANTIANGIOGENIC BICYCLIC DERIVATIVES ASTRAZENECA AB (SE) 2002-02-28 WO disclosed
WO-2002012228-A1 CINNOLINE COMPOUNDS ASTRAZENECA AB (SE) 2002-02-14 WO disclosed
WO-2002012227-A2 INDOLE, AZAINDOLE AND INDAZOLE DERIVATIVES HAVING VEGF INHIBITING ACTIVITY ASTRAZENECA AB (SE) 2002-02-14 WO disclosed